GD3 (Genesis Drug Discovery & Development) provides contract services to advance NASH research. All areas of preclinical drug discovery and development are supported including:
- DMPK/in-vivo Pharmacology and Toxicology
- Synthetic, Medicinal and Process Chemistry (including IND and IP support)
- Discovery Biology, Hit to Lead and Lead Optimization
- Assay and Biomarker development
GD3’s capabilities and expertise also expand to cover a wide range of therapeutic areas including metabolic diseases, oncology, inflammation, autoimmunity and ophthalmology.
Example Resource Snippets x 2
Team Members
Profile 1- Name
Profile 1- Job Title